These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1219 related articles for article (PubMed ID: 8795142)

  • 1. Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells.
    Ostrand-Rosenberg S; Baskar S; Patterson N; Clements VK
    Tissue Antigens; 1996 May; 47(5):414-21. PubMed ID: 8795142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.
    Baskar S; Clements VK; Glimcher LH; Nabavi N; Ostrand-Rosenberg S
    J Immunol; 1996 May; 156(10):3821-7. PubMed ID: 8621919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cells expressing major histocompatibility complex class II and B7 activation molecules stimulate potent tumor-specific immunity.
    Baskar S; Nabavi N; Glimcher LH; Ostrand-Rosenberg S
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):209-15. PubMed ID: 8297902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.
    Baskar S; Ostrand-Rosenberg S; Nabavi N; Nadler LM; Freeman GJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5687-90. PubMed ID: 7685909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes.
    Ostrand-Rosenberg S; Roby C; Clements VK; Cole GA
    Int J Cancer Suppl; 1991; 6():61-8. PubMed ID: 1906055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reassessment of the role of B7-1 expression in tumor rejection.
    Wu TC; Huang AY; Jaffee EM; Levitsky HI; Pardoll DM
    J Exp Med; 1995 Nov; 182(5):1415-21. PubMed ID: 7595212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of mouse sarcoma cells after transfection of MHC class II genes.
    Ostrand-Rosenberg S; Thakur A; Clements V
    J Immunol; 1990 May; 144(10):4068-71. PubMed ID: 2332639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
    Townsend SE; Su FW; Atherton JM; Allison JP
    Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
    Cavallo F; Martin-Fontecha A; Bellone M; Heltai S; Gatti E; Tornaghi P; Freschi M; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1995 May; 25(5):1154-62. PubMed ID: 7539748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells.
    Ljunggren G; Anderson DJ
    J Reprod Immunol; 1998 Jul; 38(2):123-38. PubMed ID: 9730287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells.
    Fallarino F; Ashikari A; Boon T; Gajewski TF
    Int Immunol; 1997 Sep; 9(9):1259-69. PubMed ID: 9310829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
    Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
    Li Y; Hellstrom KE; Newby SA; Chen L
    J Exp Med; 1996 Feb; 183(2):639-44. PubMed ID: 8627175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
    Leach DR; Callahan GN
    J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
    Ilkovitch D; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
    Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
    J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of mouse cardiac allografts by costimulation in trans.
    Mandelbrot DA; Kishimoto K; Auchincloss H; Sharpe AH; Sayegh MH
    J Immunol; 2001 Aug; 167(3):1174-8. PubMed ID: 11466331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.